SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-22-002288
Filing Date
2022-01-18
Accepted
2022-01-18 11:30:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 6 TO SCHEDULE 13G ea154093-13ga6alpha_gtbio.htm SC 13G/A 29473
  Complete submission text file 0001213900-22-002288.txt   31346
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Subject) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-32837 | Film No.: 22534203
SIC: 2834 Pharmaceutical Preparations

Mailing Address LETTSTRASSE 32 FL-9490 VADUZ N2 00000
Business Address LETTSTRASSE 32 FL-9490 VADUZ N2 00000 011-423-2323195
ALPHA CAPITAL ANSTALT (Filed by) CIK: 0001140358 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N2
Type: SC 13G/A